Clinical trial
Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Adenocarcinoma of the Stomach or Gastroesophageal Junction. A Non-interventional Study
NCT02305043 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Adenocarcinoma of the Stomach or Gastroesophageal Junction. A Non-interventional Study
- Lead sponsor
- University of Leipzig
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- January 31, 2018
- Enrollment
- 549 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.